@article{f9e57474e0b94bde8aa1f9a60af80ff1,
title = "Niche Laminin and IGF-1 Additively Coordinate the Maintenance of Oct-4 Through CD49f/IGF-1R-Hif-2α Feedforward Loop in Mouse Germline Stem Cells",
abstract = "The mechanism on how extracellular matrix (ECM) cooperates with niche growth factors and oxygen tension to regulate the self-renewal of embryonic germline stem cells (GSCs) still remains unclear. Lacking of an appropriate in vitro cell model dramatically hinders the progress. Herein, using a serum-free culture system, we demonstrated that ECM laminin cooperated with hypoxia and insulin-like growth factor 1 receptor (IGF-1R) to additively maintain AP activity and Oct-4 expression of AP+GSCs. We found the laminin receptor CD49f expression in d2 testicular GSCs that were surrounded by laminin. Laminin and hypoxia significantly increased the GSC stemness-related genes, including Hif-2α, Oct-4, IGF-1R, and CD49f. Cotreatment of IGF-1 and laminin additively increased the expression of IGF-IR, CD49f, Hif-2α, and Oct-4. Conversely, silencing IGF-1R and/or CD49f decreased the expression of Hif-2α and Oct-4. The underlying mechanism involved CD49f/IGF1R-(PI3K/AKT)-Hif-2α signaling loop, which in turn maintains Oct-4 expression, symmetric self-renewal, and cell migration. These findings reveal the additive niche laminin/IGF-IR network during early GSC development.",
keywords = "extracellular matrix, germline stem cell, hypoxia, IGF, laminin, niche, self-renewal",
author = "Au, {Heng Kien} and Peng, {Syue Wei} and Guo, {Chin Lin} and Lin, {Chien Chia} and Wang, {Yi Lin} and Kuo, {Yung Che} and Law, {Tsz Yau} and Ho, {Hong Nerng} and Ling, {Thai Yen} and Huang, {Yen Hua}",
note = "Funding Information: Funding. This work was financially supported by research grants from the Ministry of Science and Technology, Taiwan (Grant numbers: MOST 105-2628-B-038-008-MY3, MOST 106-3114-B-038-001, MOST 107-2321-B-038-002, MOST 107-2314-B-038-057, MOST 107-2314-B-038-061, MOST 108-2320-B-038-033-MY3, MOST108-2314-B-038-006, MOST 108-2321-B-038-003, MOST109-2314-B-038-135, and MOST109-2321-B-038-003); Health and Welfare Surcharge of Tobacco Products (Grant numbers: MOHW 103-TD-B-111-01, MOHW 104-TDU-B-212-124-001, MOHW 105-TDU-B-212-134001, MOHW 106-TDU-B212-144001, MOHW 107-TDU-B-212-114014, and MOHW108-TDU-B-212-124014); Taipei Medical University (Grant numbers: TMU-T104-06, TMU-T105-06, TMU-T106-03, and 105TMUCIT-01-3); BioSeed International Co., Ltd. (A-108-093 and A-110-002) to Y-HH. Taipei Medical University Hospital (Grant numbers: 104TMU-TMUH-04 and 105TMU-TMUH-10) to H-KA. C-LG acknowledges financial support from MOST 104-2112-M-001-043-MY3, MOST 105-2627-M-001-006-, MOST 106-2627-M-001-005-, MOST 107-2627-M-001-001-, MOST 107-2119-M-001-039-, MOST 107-2112-M-001-040-MY3, and MOST 108-2119-M-001-018- as well as that from AS-105-TPA04 and AS-TP-109-M04. Publisher Copyright: {\textcopyright} Copyright {\textcopyright} 2021 Au, Peng, Guo, Lin, Wang, Kuo, Law, Ho, Ling and Huang.",
year = "2021",
month = jul,
day = "26",
doi = "10.3389/fcell.2021.646644",
language = "English",
volume = "9",
journal = "Frontiers in Cell and Developmental Biology",
issn = "2296-634X",
publisher = "Frontiers Media S. A.",
}